Jundong Lin

Guangzhou International Bio Island
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Engineering endoplasmic reticulum targeted metal-polyphenol curcumin nanomicelles for melanoma therapy.

Engineering endoplasmic reticulum targeted metal-polyphenol curcumin nanomicelles for melanoma therapy.

Journal: Journal of nanobiotechnology

Published: October 06, 2025

Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming.

Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming.

Journal: Seminars in oncology

Published: August 21, 2025

Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.

Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.

Journal: Signal transduction and targeted therapy

Published: April 30, 2025

A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer.

A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer.

Journal: Journal of Cancer

Published: February 21, 2025

Precision targeted melanoma therapy via cuproptosis/chemodynamic and chemotherapy: An engineering MCHS-CuMOF nanodelivery system.

Precision targeted melanoma therapy via cuproptosis/chemodynamic and chemotherapy: An engineering MCHS-CuMOF nanodelivery system.

Journal: Biomaterials advances

Published: November 18, 2024

SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer.

SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer.

Journal: Anticancer research

Published: October 10, 2024

A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.

A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.

Journal: International journal of nanomedicine

Published: January 22, 2024

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.

Journal: Cell death & disease

Published: September 29, 2023

Molecular predictors of metastasis in patients with prostate cancer.

Molecular predictors of metastasis in patients with prostate cancer.

Journal: Expert review of molecular diagnostics

Published: March 02, 2023

Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis.

Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: August 16, 2022

Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles.

Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles.

Journal: Biomaterials advances

Published: September 24, 2021

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.

Journal: Frontiers in genetics

Published: April 30, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026